Miriam Bornhorst, MD

Dr. Bornhorst is a Neuro-Oncologist, the Clinical Director of the Gilbert Neurofibromatosis Institute at Children’s National Medical Center, Medical Director of the Cancer Genetics Program at Children’s National Hospital and an Assistant Professor in the George Washington University Department of Pediatrics. In the clinic, she primarily cares for patients with Neurofibromatosis or other predisposition to develop tumors/cancer. She is the institutional PI for many of the Mek-inhibitor and targeted treatment studies for patients with NF1 at Children’s National. Her initial laboratory research focused on the development of early intervention therapies for optic pathway gliomas in NF. She is now focusing on the identification of novel genomic and metabolomic biomarkers in patients with central and peripheral nervous system tumors, particularly in patients who have cancer predisposition syndromes and brain tumors. She has played an active role in the Children’s National post-mortem program since 2016.

Recent and Notable Publications